山河药辅:2025年净利润约为1.65亿元至1.94亿元,同比增长38.16%至62.45%

Group 1 - The company expects a net profit attributable to shareholders for the year 2025 to be between 165 million and 194 million yuan, representing a growth of 38.16% to 62.45% compared to the previous year's profit of 119 million yuan [1] - The expected net profit after deducting non-recurring items is projected to be between 147 million and 175 million yuan, indicating a year-on-year increase of 45.32% to 73.00% [1] - The company reported a strong order flow for its main products, showing significant growth momentum during the reporting period [1] Group 2 - The company's foreign trade business continues to maintain high growth, contributing to overall revenue growth alongside domestic trade [1] - In the previous year, the company recognized an impairment of goodwill amounting to 39.13 million yuan for its controlling subsidiary's asset group, which had a significant impact on profits; however, there is no such impairment recognized in the current reporting period [1]

SUNHERE-山河药辅:2025年净利润约为1.65亿元至1.94亿元,同比增长38.16%至62.45% - Reportify